Whole blood donor iron management across Europe
Whole blood donors lose iron while donating and frequent blood donation is therefore known to induce a risk of iron[…]
Presentations: Webinar Exploring the Potential of human Platelet Lysate
We are pleased to share the highlights from our recent webinar on the applications and advancements of human platelet lysate,[…]
MSM policy and PrEP/PEP
Blood donation eligibility policies for men who have sex with men (MSM) have evolved since they were found to be[…]
Towards standardized human platelet lysate production in Europe:
An initiative of the European Blood Alliance Human platelet lysate (hPL) is a supplement for cell culture media that can[…]
Overview strategies for blood donor selection vCJD
Several recent publications on transfusion risk assessment of variant Creutzfeldt-Jakob disease (vCJD) have led to changes in donor selection criteria[…]
Current transfusion practice and need for new blood products to ensure blood supply for patients with major hemorrhage in Europe
Read the full article in the Transfusion journal. Background New blood products are considered for treatment of patients with major[…]
EBA Whole Blood Webinar Presentations
On December 9th, the European Blood Alliance (EBA) presented the “Implementation of Whole Blood for Transfusion” webinar, supported by the[…]
Recommendations for in vitro evaluation of blood components collected, prepared and stored in non-DEHP medical devices
Read the full article in Vox Sanquinis Background and Objectives DEHP, di(2-ethylhexyl) phthalate, is the most common member of the[…]
The European Travelling donors’ risk assessment tool
Since 2015 the EUFRAT risk assessment tool has been publicly available on the website of the European Centre for Disease[…]